Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
8.88
-0.44 (-4.72%)
Aug 26, 2026, 1:09 PM CST

Meribank Biotech Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8941,4382,4632,392--
Market Cap Growth
-39.66%-41.61%2.99%---
Enterprise Value
1,7912,4502,5422,260--
Last Close Price
9.3216.3527.9938.09--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.193.056.7210.21--
PB Ratio
0.751.142.023.56--
P/TBV Ratio
2.433.427.263.81--
P/FCF Ratio
14.3116.80----
P/OCF Ratio
12.7716.08----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
4.395.196.949.64--
EV/EBITDA Ratio
34.61339.46----
EV/FCF Ratio
28.6628.62----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.910.900.770.050.100.09
Debt / EBITDA Ratio
18.9311.04----
Debt / FCF Ratio
17.2413.17----
Net Debt / Equity Ratio
0.750.710.64-0.54-0.34-0.40
Net Debt / EBITDA Ratio
-23.30124.46-15.323.301.652.71
Net Debt / FCF Ratio
14.1810.49-2.7110.293.567.72
Asset Turnover
0.150.170.200.250.200.19
Inventory Turnover
34.6930.5219.0112.4414.1722.33
Quick Ratio
1.531.711.434.213.304.54
Current Ratio
1.711.901.694.493.604.79
Return on Equity (ROE)
-11.33%-6.63%-10.27%-22.62%-19.46%-20.48%
Return on Assets (ROA)
-2.37%-1.19%-2.94%-8.01%-7.65%-7.25%
Return on Capital Employed (ROCE)
-4.20%-2.00%-3.60%-13.10%-14.90%-11.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-15.10%-5.66%-3.84%-5.24%--
FCF Yield
6.99%5.95%-11.64%-1.48%--
Buyback Yield / Dilution
-9.70%-14.85%-26.54%-0.11%-4.07%-14.52%